
        <!DOCTYPE html>
        <html lang="en">
        <head>
            <meta charset="UTF-8">
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <title>Mithracin - Cluster Assets</title>
            <link rel="stylesheet" href="../style.css">
        </head>
        <body>
            <div class="container">
                <header><h1>Mithracin</h1></header>
                <main>
                    <table class='micro-assets'><tbody><tr><td class='num-col'>1</td><td class='emoji-col'>ğŸ’Š</td><td class='summary-col'><a class='summary-link' href='#c1'><span class='summary-title'>cancer drug</span> <span class='summary-meta'><span class='tag tag-sm'>medicine</span></span><span class='summary-collocation'><b>Mithracin</b> cancer treatment</span></a></td></tr></tbody></table>
                    <section id='c1' class='concept-entry'><h2>1. ğŸ’Š cancer drug ("Mithracin cancer treatment")</h2><div class='part-of-speech'>NOUN</div><div class='headword-pronunciation'>Pronunciation: / ËˆmÉªÎ¸.rÉ™.sÉªn / (AmE), / ËˆmÉªÎ¸.rÉ™.sÉªn / (BrE)</div><div class='definition'>A trademarked antineoplastic drug formerly used in the treatment of testicular cancer.</div><div class='sense-short-description'>antineoplastic drug; trademark name</div><div class='examples'><h3>Examples</h3><blockquote>Researchers monitored the side effects of <b>Mithracin</b> in clinical studies.</blockquote><blockquote>The oncologist discussed the risks associated with <b>Mithracin</b> therapy for testicular cancer.</blockquote><blockquote>Use of <b>Mithracin</b> has declined due to the development of more effective drugs.</blockquote></div><div><h3>Senses in This Cluster</h3><ul><li><code>Mithracin|oewn-03780206-n</code> â€“ antineoplastic drug; trademark name</li></ul></div></section>
                </main>
                <footer><p class="muted">Cluster assets derived from dictionary data</p></footer>
            </div>
        </body>
        </html>
    